Both protein (P = 0.0116) and mRNA expression levels (P = 0.0072) of TAGLN were significantly downregulated in breast tumors in comparison to non-tumor tissues (Fig. 5a, b). This evidence concerns the gene TAGLN and breast neoplasm.